πŸ‡ΊπŸ‡Έ FDA
Patent

US 11787800

BRD9 degraders and uses thereof

granted A61PA61P35/00

Quick answer

US patent 11787800 (BRD9 degraders and uses thereof) held by FOGHORN THERAPEUTICS INC. expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
FOGHORN THERAPEUTICS INC.
Grant date
Tue Oct 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61P, A61P35/00